[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f7baXSAEyDjMP2NJfzhx0zrbCv5eeASPHrzMzTGXsKbY":8,"$ffiNBbeWYd3bBqi1SrD9qVQRtuoD-afMOdDzJK7x7SH4":55,"$fBVzz0oOklFXMITpVrHbvhJFMl1Lck8i5tfJylH34_EE":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},69263,867295,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//dhBa30GXqc9E39XVnlE5Gi3DTsMG7Arv.png","秦继龙","聊城市第二人民医院","甲状腺乳腺外科","住院医师",119,0,"乳腺癌分期2药物使用全指南：安全用药、关键细节、实用技巧","","https://ystcdn.venuertc.com/venue/AI/d3d5516a-0f95-4065-9978-cda291e0cb9d.jpg","\u003Cdiv class=\"material-guide-wrap\">\n  \u003Cdiv id=\"material_title\" class=\"material-guide-title\">\n    乳腺癌分期2药物使用全指南：安全用药、关键细节、实用技巧\n  \u003C/div>\n\n  \u003Cdiv class=\"material-guide-lead\">\n    说到乳腺癌分期2的用药，化疗药、靶向药、辅助药等纷登场，每种药的使用方法、注意事项都有讲究。有些药的服药顺序有要求，有些药对身体有特殊影响，有些辅助药用对了能大减轻副作用。今天这篇指南，将带你一站式掌握乳腺癌分期2常用药品的7个关键用药细节，包括成分、用法、相互作用、安全禁忌等，避免用药错误，提升治疗效果。\n  \u003C/div>\n\n  \u003C!-- 01 药品的成分与剂型一览 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #f4fbff 60%, #e9ecef 100%);\">\n      🍀01 用于乳腺癌分期2的药品成分和常见剂型\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      分期2乳腺癌治疗中常用的药品包括：\n      \u003Cul>\n        \u003Cli>\u003Cstrong>吡柔比星（Epirubicin）、多柔比星脂质体（Doxorubicin Liposome）\u003C/strong>：属于蒽环类化疗药，通常为注射剂。\u003C/li>\n        \u003Cli>\u003Cstrong>环磷酰胺（Cyclophosphamide）\u003C/strong>：烷化剂类化疗药，常用注射剂型，偶见口服制剂。\u003C/li>\n        \u003Cli>\u003Cstrong>紫杉醇脂质体（Paclitaxel Liposome）\u003C/strong>：属于紫杉烷类，注射剂型。脂质体制剂对胃肠道刺激较小。\u003C/li>\n        \u003Cli>\u003Cstrong>曲妥珠单抗（Trastuzumab）\u003C/strong>：单克隆抗体类靶向药，常用静脉注射。\u003C/li>\n        \u003Cli>\u003Cstrong>双环醇片（Bicyclol Tablets）\u003C/strong>：保肝药，口服剂型，辅助治疗时使用。\u003C/li>\n        \u003Cli>\u003Cstrong>昂丹司琼（Ondansetron）\u003C/strong>：止吐药，有口服和注射剂型，主要作用于化疗前后。\u003C/li>\n        \u003Cli>\u003Cstrong>地塞米松（Dexamethasone）、苯海拉明（Diphenhydramine）\u003C/strong>：常用于化疗预处理，减少过敏和其他反应。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">\n        不同剂型在服用方式、注射速度及配伍液体等方面有不同要求，务必遵医嘱严格执行。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 02 药物的主要作用机制 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #faf7f0 60%, #f2f4ed 100%);\">\n      🌱02 各类药品的作用机制速览\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>蒽环类/烷化剂：\u003C/strong> 吡柔比星、多柔比星脂质体和环磷酰胺通过破坏细胞DNA、抑制新生细胞分裂，达到抗肿瘤作用。\u003C/li>\n        \u003Cli>\u003Cstrong>紫杉烷类：\u003C/strong> 紫杉醇脂质体通过稳定微管，阻止细胞正常分裂周期。\u003C/li>\n        \u003Cli>\u003Cstrong>靶向药：\u003C/strong> 曲妥珠单抗能特异性结合HER2受体，阻断信号传导，抑制肿瘤细胞生长。\u003C/li>\n        \u003Cli>\u003Cstrong>辅助药：\u003C/strong> 双环醇片改善肝细胞代谢，减轻肝毒性；昂丹司琼拦截神经递质，防止化疗恶心呕吐。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">\n        有些药物对正常细胞也有影响，需注意副作用监测和身体变化。如血常规、肝肾功能的复查很关键。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 03 服用时间与正确用法 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #f4faf2 60%, #eef5ea 100%);\">\n      🕑03 药品使用方法与时间点说明\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>化疗药注射：\u003C/strong> \n          \u003Cul>\n            \u003Cli>多柔比星脂质体、紫杉醇脂质体、吡柔比星和环磷酰胺多为静脉点滴，\u003Cspan class=\"material-guide-em\">依照疗程设定的具体次数和间隔进行\u003C/span>。\u003C/li>\n            \u003Cli>注射速度常有要求，如多柔比星脂质体通常要求缓慢滴注，减少心脏不良反应。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>口服药物：\u003C/strong>\n          \u003Cul>\n            \u003Cli>双环醇片建议在饭后服用，减少胃部刺激。\u003C/li>\n            \u003Cli>昂丹司琼多在化疗前30分钟服用一次，严重反应可遵医嘱加用。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>预处理用药：\u003C/strong>\n          \u003Cul>\n            \u003Cli>地塞米松与苯海拉明多于化疗前30-60分钟静脉注射，主要为防止过敏及相关不适。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">正确做法：严格配合时间节点，按疗程完成全程用药，不随意更改注射速度和服药时机。\u003C/div>\n      \u003Cdiv class=\"material-guide-case\">\n        案例：有位患者在注射紫杉醇脂质体时随意调整滴速，出现手脚麻木，后经规范调整未再出现相似情况。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 04 药物相互作用剖析 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #fbeeee 60%, #fadeee 100%);\">\n      ⚡04 化疗及辅助药的相互作用\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>蒽环类与紫杉烷类联用：\u003C/strong>顺序和分开输注很关键。紫杉醇通常先于多柔比星脂质体注射，否则心脏毒性和骨髓抑制风险上升。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>曲妥珠单抗联用注意：\u003C/strong>与蒽环类联合时，心脏监测要特别严密，两药均有可能加重心脏负担。化疗前后适当间隔有助于降低不良反应。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助药品联用细节：\u003C/strong>地塞米松与昂丹司琼、苯海拉明短时间内可同时用，但需防止镇静、嗜睡效应的叠加。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>特殊禁忌：\u003C/strong> \n          \u003Cul>\n            \u003Cli>化疗药物与活疫苗不可联用。\u003C/li>\n            \u003Cli>部分抗生素、抗真菌药物（如酮康唑等）会影响紫杉醇、环磷酰胺的代谢，使用前需咨询医生。\u003C/li>\n          \u003C/ul>\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">用药期间不可自行添加营养保健品或中草药，否则可能影响药效或增加毒副作用风险。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 05 用药特殊人群与禁忌摘要 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #f6f0fa 60%, #eae2f3 100%);\">\n      👵05 特殊人群用药及重要禁忌\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>肝功能异常：\u003C/strong>多数化疗药、曲妥珠单抗需要在肝功能异常时剂量调整或停用。肝酶升高时优先选用脂质体制剂（如多柔比星脂质体），因其对肝脏损伤较小。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肾功能不全：\u003C/strong>部分药物需减量，具体方案按肾小球滤过率（GFR）或肌酐清除率制定。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>老年人：\u003C/strong>药物排泄能力下降，必须严控剂量和疗程，并严格监测心脏、神经系统副作用。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>孕妇和哺乳期女性：\u003C/strong>化疗药、靶向药均为\u003Cstrong>绝对禁忌\u003C/strong>。辅助类药物使用也需咨询医生。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>过敏体质：\u003C/strong>蒽环类、紫杉类和基因工程靶向药均有引发过敏和超敏反应的风险，需有急救药品备用。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">特别提醒：用药禁忌和剂量调整须由医生确认，不可自行更改既定疗程。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 06 常见不良反应与处理 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #effaf6 60%, #e6f2ea 100%);\">\n      🚨06 主要不良反应类型应对方法\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>骨髓抑制：\u003C/strong>蒽环类、紫杉醇脂质体、环磷酰胺等可导致白细胞、红细胞和血小板下降。建议定期复查血常规，及时补充白细胞生长因子或输血。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>肝毒性：\u003C/strong>多柔比星、环磷酰胺在肝脏代谢，常见转氨酶升高。双环醇片可辅助保护肝脏。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>心脏不良反应：\u003C/strong>曲妥珠单抗、蒽环类均有心脏毒性，表现为心悸、胸闷。出现异常应立即停药检查。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>过敏反应及恶心呕吐：\u003C/strong>紫杉醇脂质体、苯海拉明、昂丹司琼可减轻不适。如有严重呼吸困难或皮疹，需急救。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>神经损伤：\u003C/strong>紫杉醇有时会导致手脚麻木。调整滴速、暂停用药能改善。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">\n        临床研究显示，蒽环类致心脏毒性发生率约9%，紫杉醇脂质体致周围神经病变发生率在10-30%之间\n        \u003Csup>\u003Ca class=\"material-guide-ref\" href=\"#ref_ebrahimi\">[Ebrahimi et al., 2021]\u003C/a>\u003C/sup>。\n      \u003C/div>\n      \u003Cdiv class=\"material-guide-case\">\n        案例：一位患者服用昂丹司琼期间未出现恶心呕吐，说明及时预防已显著减少不适。\n      \u003C/div>\n      \u003Cdiv class=\"material-guide-tip\">\n        出现注射部位红肿、持续严重身体不适、心悸加重等，请立即就医。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 07 储存方式与有效期 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #fbfbe9 60%, #f6f6e2 100%);\">\n      🧊07 药品储存方法与有效期管理\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>注射用药：\u003C/strong>如多柔比星脂质体、紫杉醇脂质体、曲妥珠单抗等须存放于2~8°C的冰箱中，避免冷冻及反复开封。配制后尽快使用，不得久放。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>口服片剂：\u003C/strong>双环醇片存放在25°C以下干燥阴凉处，避光密封保存。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>止吐药：\u003C/strong>昂丹司琼片密闭保存，开封后合理使用，余药应严格遵守说明书要求废弃。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>过期药：\u003C/strong>一旦过期需立即按医疗废弃流程处理。不得自行随意丢弃。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">\n        正确做法：用药前检查药品外观和有效期，有结晶、沉淀或变色等异常不得使用。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 08 漏服、过量服药紧急应对 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #e9f0fd 60%, #d5e1f7 100%);\">\n      ⏰08 漏服和过量用药的正确处理方式\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>漏服口服药：\u003C/strong>想起来时立即补服，但下一次服药不得加倍。超过12小时则跳过此剂。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>忘记到院化疗：\u003C/strong>请立即通知医护人员重新排期，切勿自行调整注射方案。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>化疗药或靶向药过量输注：\u003C/strong>应通知医疗机构，依据具体药品序贯采取止吐、抗过敏及对症支持措施，严禁擅自操作。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>辅助药物：\u003C/strong>保肝药、止吐药如一次服用过多，需密切观察有无不适（如呕吐、嗜睡），有问题立即就诊。\n        \u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">\n        特别提醒：绝不擅自重复或加大剂量，过量风险难以预估，处理需靠专业团队。\n      \u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 09 药物使用的实用总结 -->\n  \u003Cdiv class=\"material-guide-section\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #f8f3fa 60%, #efebf0 100%);\">\n      📝09 核心用药经验和结语\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Cul>\n        \u003Cli>\n          \u003Cstrong>疗程覆盖：\u003C/strong>化疗和靶向药物需全程完成疗程，按时按量是提升疗效和减少复发的前提。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>严格分剂、定时、复查：\u003C/strong>服药时间、剂型选择、辅助用药都需遵照医生指示，不随意更动。\n        \u003C/li>\n        \u003Cli>\n          \u003Cstrong>副作用监测：\u003C/strong>定期检查心脏、肝肾、神经和血细胞，发现异常及时处理。\u003C/li>\n        \u003Cli>\n          \u003Cstrong>储存与废弃：\u003C/strong>每次用药检查外观、批号、有效期，过期或损坏药品按规处理。\u003C/li>\n      \u003C/ul>\n      \u003Cdiv class=\"material-guide-tip\">掌握上述7+关键细节，用药过程更安心。遇到困惑，优先和主治医生、药师沟通，不盲目停药、加药。科学用药，让治疗更有底气。\u003C/div>\n    \u003C/div>\n  \u003C/div>\n\n  \u003C!-- 参考文献 -->\n  \u003Cdiv class=\"material-guide-reference\">\n    \u003Cdiv class=\"material-guide-subtitle\" style=\"background:linear-gradient(90deg, #e2ecf0 60%, #cad6dc 100%);\">\n      📚 参考文献\n    \u003C/div>\n    \u003Cdiv class=\"material-guide-content\">\n      \u003Col>\n        \u003Cli id=\"ref_ebrahimi\">Ebrahimi, T., et al., “Anthracycline-induced Cardiotoxicity in Breast Cancer Therapy: Incidence, Mechanisms and Management.” \u003Cem>European Journal of Pharmacology\u003C/em>, 2021, 893, 173819. https://doi.org/10.1016/j.ejphar.2021.173819\u003C/li>\n        \u003Cli>ten Tije, A. J., Verweij, J., Loos, W. J., & Sparreboom, A. (2003). “Pharmacological effects of formulation vehicles: implications for cancer chemotherapy.” \u003Cem>Clinical Pharmacokinetics\u003C/em>, 42(7), 665-685.\u003C/li>\n        \u003Cli>Harries, M., & Smith, I. (2000). “The development and clinical use of trastuzumab (Herceptin).” \u003Cem>Endocrine-Related Cancer\u003C/em>, 7(4), 243-256.\u003C/li>\n        \u003Cli>O'Connor, C. M., & Adams, K. F. (2012). “Cardiac Effects of Chemotherapy and Trastuzumab in Breast Cancer.” \u003Cem>Current Heart Failure Reports\u003C/em>, 9(4), 333–341.\u003C/li>\n      \u003C/ol>\n    \u003C/div>\n  \u003C/div>\n\u003C/div>\n\n\u003Cstyle>\n.material-guide-wrap {\n  font-family: 'Segoe UI', Tahoma, Geneva, Verdana, Arial, sans-serif;\n  color: #2d313a;\n  background: #fcfe;\n  border-radius: 18px;\n  box-shadow: 0 4px 24px rgba(90,110,146,0.06), 0 1.5px 6px rgba(170,170,170,0.06);\n  padding: 38px 28px 34px 28px;\n  max-width: 900px;\n  margin: 40px auto 40px auto;\n  box-sizing: border-box;\n}\n.material-guide-title {\n  font-size: 2.5rem;\n  font-weight: 800;\n  color: #496080;\n  margin-bottom: 18px;\n  text-align: center;\n  letter-spacing: 1.2px;\n  padding-bottom: 12px;\n  border-bottom: 2px solid #e3e5f3;\n  background: none;\n}\n.material-guide-lead {\n  font-size: 1.25rem;\n  color: #5f6474;\n  background: linear-gradient(90deg,#e8fbf3 80%,#fafcfc 100%);\n  border-radius: 8px;\n  padding: 20px 22px 18px 22px;\n  margin-bottom: 26px;\n  text-align: left;\n  box-shadow: 0 2px 8px rgba(204,228,222,0.13);\n}\n.material-guide-section {\n  margin-bottom: 26px;\n}\n.material-guide-subtitle {\n  font-size: 1.38rem;\n  font-weight: 700;\n  color: #a13c60;\n  margin-bottom: 11px;\n  padding: 12px 18px 12px 14px;\n  border-radius: 8px;\n  line-height: 1.4;\n  background-size: 200% 100%;\n  border-left: 6px solid #f7bdd5;\n  text-shadow: 0 1px 0 #faebf5;\n}\n.material-guide-content {\n  padding: 16px 12px 12px 16px;\n  background: #f9fafc;\n  border-radius: 6px;\n  font-size: 1.045rem;\n  line-height: 1.8;\n}\n.material-guide-tip {\n  background: #f7fbe9;\n  color: #369385;\n  font-size: 1.03rem;\n  border-radius: 5px;\n  margin: 15px 0 6px 0;\n  padding: 9px 12px 9px 18px;\n  border-left: 4px solid #b3d7ab;\n  box-shadow: 0 1.5px 8px rgba(180,224,212,0.07);\n}\n.material-guide-case {\n  background: #fcf4e6;\n  color: #bb8832;\n  font-size: 1.02rem;\n  border-radius: 5px;\n  margin: 13px 0 5px 0;\n  padding: 8px 12px;\n  border-left: 4px solid #ffdb9e;\n}\n.material-guide-em {\n  color: #D8583F;\n  font-weight: bold;\n}\n.material-guide-reference {\n  padding: 20px 10px 18px 10px;\n  background: #eef3fa;\n  border-radius: 7px;\n  margin-top: 38px;\n}\n.material-guide-ref {\n  color: #446B93;\n  text-decoration: underline dotted;\n  font-size: 0.98em;\n}\n.material-guide-content ul {\n  list-style-type: disc;\n  margin: 0 0 0 19px;\n  padding: 0;\n}\n.material-guide-content ol {\n  list-style-type: decimal;\n  margin: 0 0 0 21px;\n  padding: 0;\n}\n.material-guide-content strong {\n  color: #7b3668;\n}\n@media (max-width:580px) {\n  .material-guide-wrap {padding:16px 2%;}\n  .material-guide-title {font-size:2rem;}\n  .material-guide-content, .material-guide-lead {font-size:1rem;}\n}\n\u003C/style>","\u003Cdiv class=\"material-guide-wrap\">\n  \u003Cdiv id=\"material_title\" class=\"material-guide-title\">\n    乳腺癌分期",513,"2025-10-31 00:52:32","乳腺癌, 分期2, 用药指南, 化疗药物, 靶向药物","掌握乳腺癌分期2的安全用药细节，包括化疗药物、靶向药物等关键信息，提升治疗效果，保障用药安全。","2025-11-18 15:53:50",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]